Clinical trials
Completed Phase 3 Gout trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ardea Biosciences, Inc. | 6 |
| Takeda | 6 |
| Novartis Pharmaceuticals | 4 |
| Regeneron Pharmaceuticals | 4 |
| Savient Pharmaceuticals | 3 |
| Arthrosi Therapeutics | 2 |
| Jiangsu HengRui Medicine Co., Ltd. | 2 |
| LG Chem | 2 |
| Astellas Pharma Taiwan, Inc. | 1 |
| Eisai Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gout | 34 |
| Arthritis | 6 |
| Hyperuricemia | 6 |
| Rheumatic Diseases | 6 |
| Genetic Diseases, Inborn | 4 |
| Joint Diseases | 4 |
| Metabolic Diseases | 4 |
| Metabolism, Inborn Errors | 4 |
| Musculoskeletal Diseases | 4 |
| Purine-Pyrimidine Metabolism, Inborn Errors | 4 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.